The US Food and Drug Administration has given approval for Mumbai-based pharmaceutical company Lupin to market the generic versions of Bayer's Cipro and Aqua Pharmaceuticals' Monodox capsules in the American market. Confirming the approval, the company said that it has received permission to market Cipro oral suspension in 250 mg/ml and 500 mg/ml strengths while its Doxycycline Capsules, which are equivalent to Monodox capsules, will be marketed in strengths of 50mg, ...
Read More
You have just read an article categorized health
titled FDA Gives Approval to Lupin to Market Generic Cipro in US.
Written by:
editor -
Friday, March 7, 2014
There are currently no comments for "FDA Gives Approval to Lupin to Market Generic Cipro in US"
Post a Comment